跳转至内容
Merck
CN

OP44

APC (Ab-1)小鼠单克隆抗体(FE9)

liquid, clone FE9, Calbiochem®

别名:

抗-腺瘤性息肉病性大肠埃希菌

登录 查看组织和合同定价。

选择尺寸

关于此项目

NACRES:
NA.43
UNSPSC Code:
12352203

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

APC (Ab-1)小鼠单克隆抗体(FE9), liquid, clone FE9, Calbiochem®

biological source

mouse

antibody form

purified antibody

antibody product type

primary antibodies

clone

FE9, monoclonal

form

liquid

contains

≤0.1% sodium azide as preservative

species reactivity

rat, human, mouse

manufacturer/tradename

Calbiochem®

storage condition

do not freeze

dilution

(Immunoblotting (1 µg/mL))

isotype

IgG1

shipped in

wet ice

storage temp.

2-8°C

target post-translational modification

unmodified

Quality Level

100

Gene Information

human ... APC(324)

相关类别

Analysis Note

阳性对照
HCT116细胞用于p300，SW480细胞用于截短APC（p147）

Application

免疫印迹（1 µg/ml，参见注释）

Disclaimer

毒性：标准处理（A）

General description

可识别HCT116细胞中的全长APC（p300）和SW480细胞中的截短APC（p147）。
  • 抗体靶基因符号：APC
  • 目标同义词：AI047805，Apc7，AU020952，AW124434，BTPS2，DP2，DP2.5，DP3，家族性腺瘤性息肉病，FAP，GS，Min，RATAPC
  • Entrez基因名称：腺瘤性息肉病
  • Hu Entrez ID：324（有关抗体：OP80，ST1150，OP62，OP47L）
  • Mu Entrez ID：11789
  • 大鼠Entrez ID：24205
    • 抗APC（Ab-1），小鼠单克隆，克隆FE9，可识别HCT116细胞中的全长APC（p300）和SW480细胞中的截短APC（p147）。它已被验证可用于蛋白质印迹法。
    蛋白G纯化小鼠单克隆抗体是通过用指定的免疫原免疫小鼠并将脾细胞与SP40细胞融合而产生的。可识别~300 kDa APC蛋白以及多种截短形式。

    Immunogen

    一种与APC N端35个氨基酸对应的合成肽

    Other Notes

    Koetsier, P. A., et al. 1993.BioTechniques15, 258.
    Smith, K. J., et al. 1993.Proc.Natl.Acad.Sci., USA90, 2846.
    Su, L.-K., et al. 1993.Can.Res.53, 2728.
    Boynton, R. F., et al. 1992.Proc.Natl.Acad.Sci. USA89, 3385.
    D′Amico, D., et al. 1992.Cancer Res.52, 1996.
    Fearon, E. R., and Jones, P. A., 1992.FASEB J.6, 2783.
    Miyoshi, Y., et al. 1992.Proc.Natl.Acad.Sci. USA89, 4452.
    Powell, S. M., et al. 1992.Nature359, 235.
    Groden, J., et al. 1991.Cell66, 589.
    Kinzler, K. W., et al. 1991.Science253, 661.
    Nishisho, I., et al. 1991.Science253, 665.

    Packaging

    请参考特定浓度批号的标签。

    Physical form

    溶于50 mM磷酸钠缓冲液（pH 7.5），含0.2％明胶。

    Legal Information

    CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

    未找到合适的产品？  

    试试我们的产品选型工具.

    存储类别

    11 - Combustible Solids

    wgk

    WGK 1

    flash_point_f

    Not applicable

    flash_point_c

    Not applicable

    分析证书(COA)

    输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

    已有该产品？

    在文件库中查找您最近购买产品的文档。

    访问文档库

    Nathaniel S Rial et al.
    International journal of cancer, 124(10), 2270-2280 (2009-01-29)
    Elevated deoxycholic acid (DCA), mutations in the adenomatous polyposis coli (APC) gene and chronic inflammation are associated with increased risk of colorectal cancer. APC status was manipulated to determine whether DCA mediates inflammatory molecules in normal or initiated colonic mucosa.
    Mireia Menéndez et al.
    Gastroenterology, 134(1), 56-64 (2008-01-02)
    We identified the APC N1026S variant of unknown malignant potential in the adenomatous polyposis coli (APC) gene in a Spanish attenuated familial adenomatous polyposis (AFAP) family. The variant was located in the first of the 4 highly conserved 15-amino acid
    Tamar Evron et al.
    Oncogenesis, 10(9), 63-63 (2021-09-24)
    The Wnt signaling pathways play fundamental roles during both development and adult homeostasis. Aberrant activation of the canonical Wnt signal transduction pathway is involved in many diseases including cancer, and is especially implicated in the development and progression of colorectal
    Jason L Larabee et al.
    The Journal of biological chemistry, 286(22), 19364-19372 (2011-04-14)
    The production of cAMP from Bacillus anthracis edema toxin (ET) activates gene expression in macrophages through a complex array of signaling pathways, most of which remain poorly defined. In this study, the tumor suppressor protein adenomatous polyposis coli (APC) was
    Dipon Das et al.
    DNA repair, 24, 15-25 (2014-12-03)
    Colorectal cancer (CRC) patients with APC mutations do not benefit from 5-FU therapy. It was reported that APC physically interacts with POLβ and FEN1, thus blocking LP-BER via APC's DNA repair inhibitory (DRI) domain in vitro. The aim of this
    查看所有相关文献

    我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

    联系客户支持